Literature DB >> 29029193

Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children.

Elisa Holmlund-Suila1, Maria Enlund-Cerullo1,2, Saara Valkama1, Helena Hauta-Alus1, Jenni Rosendahl1, Otto Helve1, Timo Hytinantti1, Heli Viljakainen1,2, Sture Andersson1, Outi Mäkitie1,2,3.   

Abstract

Context: Fibroblast growth factor 23 (FGF23) plays an important role in phosphate homeostasis, but its regulation is inadequately characterized. Objective: To examine FGF23 regulators, especially sex and iron status, in early childhood. Design: A cross-sectional study involving 1-year-old children. Setting and Participants: Healthy term infants with a birth weight appropriate for gestational age were recruited to an ongoing vitamin D trial at Kätilöopisto Maternity Hospital, Helsinki, Finland. At 12-month follow-up visits, serum FGF23, 25-hydroxyvitamin D (25OHD), phosphate, ionized calcium, parathyroid hormone, and iron status were measured. All 721 children (51% girls) with complete data were included. Main Outcome Measures: Intact and C-terminal FGF23 concentrations and iron status at 1 year of age.
Results: Intact FGF23 was greater in girls than in boys [median, 44.4 pg/mL; interquartile range (IQR), 36.8 to 51.9; median, 40.9 pg/mL; IQR, 34.5 to 49.0, respectively; P < 0.001]. C-terminal FGF23 was similar in boys and girls (median, 2.8 pmol/L; IQR, 2.1 to 3.7; median, 2.9 pmol/L; IQR, 2.2 to 3.7, respectively; P = 0.393). The iron concentration was positively associated with intact FGF23 and was the strongest modifier of intact FGF23 (regression coefficient, 0.498; 95% confidence interval, 0.333 to 0.663; P < 0.001) with ferritin, season, ionized calcium, 25OHD, and sex as other covariates. The association between iron and C-terminal FGF23 was inversely related (regression coefficient, -0.072; 95% confidence interval, -0.092 to -0.051; P < 0.001). Conclusions: At 1 year of age, FGF23 status was different in girls and boys, with intact FGF23 concentrations higher in girls. Iron modified FGF23 concentrations, with intact FGF23 higher and C-terminal lower, in those with greater iron concentrations.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29029193     DOI: 10.1210/jc.2017-01211

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

Review 2.  Congenital Conditions of Hypophosphatemia in Children.

Authors:  Erik Allen Imel
Journal:  Calcif Tissue Int       Date:  2020-04-23       Impact factor: 4.333

3.  Association Between the 25-Hydroxyvitamin D Status and Physical Performance in Healthy Recreational Athletes.

Authors:  Cornelia Zeitler; Robert Fritz; Gerhard Smekal; Cem Ekmekcioglu
Journal:  Int J Environ Res Public Health       Date:  2018-12-03       Impact factor: 3.390

4.  Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.

Authors:  Clotilde Roy; Sibille Lejeune; Alisson Slimani; Christophe de Meester; Sylvie A Ahn As; Michel F Rousseau; Amzulescu Mihaela; Audrey Ginion; Benjamin Ferracin; Agnès Pasquet; David Vancraeynest; Christophe Beauloye; Jean-Louis Vanoverschelde; Sandrine Horman; Damien Gruson; Bernhard L Gerber; Anne-Catherine Pouleur
Journal:  ESC Heart Fail       Date:  2020-06-24

5.  Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.

Authors:  Petra Loid; Helena Hauta-Alus; Outi Mäkitie; Per Magnusson; Riikka E Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

6.  Food and Nutrient Intake and Nutrient Sources in 1-Year-Old Infants in Finland: A Cross-Sectional Analysis.

Authors:  Helena H Hauta-Alus; Liisa Korkalo; Elisa M Holmlund-Suila; Jenni Rosendahl; Saara M Valkama; Maria Enlund-Cerullo; Otto M Helve; Timo K Hytinantti; Outi M Mäkitie; Sture Andersson; Heli T Viljakainen
Journal:  Nutrients       Date:  2017-12-01       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.